Natarajan Ravendhran
- Hepatology top 1%
- Epidemiology top 5%
- Infectious Diseases top 10%
- Rheumatology top 10%
- Molecular Biology
- Co-authors
- Jonathan McConeIra M. JacobsonLorenzo RossaroMitchell DavisJoseph GalatiJohn M. VierlingFrank AndersonPaul Y. Kwo
- Topics
- Hepatitis C virus research (23 papers)Liver Disease Diagnosis and Treatment (15 papers)Hepatitis B Virus Studies (10 papers)
- Journals
- The LancetGastroenterologyHepatology
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Natarajan Ravendhran
29 papers receiving 900 citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Hepatology 821
- Epidemiology 767
- Infectious Diseases 188
- Rheumatology 86
- Molecular Biology 56
Countries citing papers authored by Natarajan Ravendhran
This map shows the geographic impact of Natarajan Ravendhran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natarajan Ravendhran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natarajan Ravendhran more than expected).
Fields of papers citing papers by Natarajan Ravendhran
This network shows the impact of papers produced by Natarajan Ravendhran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natarajan Ravendhran. The network helps show where Natarajan Ravendhran may publish in the future.
Co-authorship network of co-authors of Natarajan Ravendhran
This figure shows the co-authorship network connecting the top 25 collaborators of Natarajan Ravendhran. A scholar is included among the top collaborators of Natarajan Ravendhran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natarajan Ravendhran. Natarajan Ravendhran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 59 | |
| 2 | 4 | |
| 3 | 22 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 18 | |
| 11 | 2 | |
| 12 | 16 | |
| 13 | 2 | |
| 14 | 49 | |
| 15 | 1 | |
| 16 | 4 | |
| 17 | 36 | |
| 18 | Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trialbreakdown → | 515 |
| 19 | 31 | |
| 20 | 6 |
About Natarajan Ravendhran
Natarajan Ravendhran is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 30 papers that have together received 923 indexed citations. Recurring topics across this work include Hepatitis C virus research (23 papers), Liver Disease Diagnosis and Treatment (15 papers) and Hepatitis B Virus Studies (10 papers). The work is most often cited by research in Hepatology (821 citations), Epidemiology (767 citations) and Infectious Diseases (188 citations). Natarajan Ravendhran has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Jonathan McCone, Ira M. Jacobson, Lorenzo Rossaro, Mitchell Davis, Joseph Galati, John M. Vierling, Frank Anderson, Paul Y. Kwo, Raymond A. Rubin and Eric Lawitz. Their work appears in journals such as The Lancet, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.